Michael Mayersohn
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 27
- Antibiotics Pharmacokinetics and Efficacy 20
- Pharmaceutical Science top 0.5%
- Drug Solubulity and Delivery Systems 10
- Toxicology top 1%
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 27
- Antibiotics Pharmacokinetics and Efficacy 20
- Analytical Chemistry top 1%
- Analytical Methods in Pharmaceuticals 17
-
- Analytical Chemistry and Chromatography 18
-
- Drug Transport and Resistance Mechanisms 17
-
- Neurotransmitter Receptor Influence on Behavior 12
-
- Pharmaceutical studies and practices 11
- Co-authors
- Donald PerrierHuadong TangMilo GibaldiJohn CobbyArturo Lopez‐AnayaS. Michael OwensD.G. PerrierTarundeep Kakkar
- Journals
- Journal of Pharmaceutical Sciences (22 papers)Drug Metabolism and Disposition (17 papers)Journal of Pharmacology and Experimental Therapeutics (10 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Michael Mayersohn
159 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 156
- Pharmacology 692
- Pharmaceutical Science 443
- Toxicology 125
- Pharmacology 579
- Analytical Chemistry 305
Countries citing papers authored by Michael Mayersohn
This map shows the geographic impact of Michael Mayersohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Mayersohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Mayersohn more than expected).
Fields of papers citing papers by Michael Mayersohn
This network shows the impact of papers produced by Michael Mayersohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Mayersohn. The network helps show where Michael Mayersohn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Mayersohn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2005 | 26 | |
| 3 | 2004 | 22 | |
| 4 | 2003 | 69 | |
| 5 | 1999 | 5 | |
| 6 | 1999 | 20 | |
| 7 | 1998 | 18 | |
| 8 | 1998 | 1 | |
| 9 | 1997 | 5 | |
| 10 | 1996 | 9 | |
| 11 | 1996 | 4 | |
| 12 | 1995 | 50 | |
| 13 | 1995 | 15 | |
| 14 | 1994 | 6 | |
| 15 | 1992 | 23 | |
| 16 | Effect of food intake on the relative bioavailability of moclobemide (Ro 11-1163). | 1988 | 10 |
| 17 | 1987 | 44 | |
| 18 | Lack of influence of caffeine and aspirin on lithium elimination | 1982 | 6 |
| 19 | Thiopental kinetics in obese surgical patients | 1981 | 2 |
| 20 | Kinetics of pharmacologic response to cocaine. | 1978 | 11 |
About Michael Mayersohn
Michael Mayersohn is a scholar working on Pharmacology, Toxicology and Pharmaceutical Science, having authored 160 papers that have together received 3.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (27 papers), Antibiotics Pharmacokinetics and Efficacy (20 papers), Analytical Chemistry and Chromatography (18 papers), Drug Transport and Resistance Mechanisms (17 papers), Analytical Methods in Pharmaceuticals (17 papers), Neurotransmitter Receptor Influence on Behavior (12 papers), Pharmaceutical studies and practices (11 papers) and Drug Solubulity and Delivery Systems (10 papers). The work is most often cited by research in Pharmacology (692 citations), Pharmaceutical Science (443 citations) and Toxicology (125 citations). Michael Mayersohn has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Donald Perrier, Huadong Tang, Milo Gibaldi, John Cobby, Arturo Lopez‐Anaya, S. Michael Owens, D.G. Perrier, Tarundeep Kakkar, Yvonne Pak and Ramanuj Achari. Their work appears in journals such as Journal of Pharmaceutical Sciences, Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, Clinical Pharmacology & Therapeutics and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.